
Collective Scientific enables pharmaceutical labs to discover novel drug candidates more quickly and effectively by transforming drug discovery into an engineering problem. Their software models de novo therapies, screening, refining, and optimizing in a single step, replacing traditional high-throughput screening. This process shortens the drug discovery timeline, allowing labs of all sizes to increase productivity and research a wider array of diseases. They provide a report with ranked, optimized compounds and their biosimilars ready for in vivo studies in under two weeks, leveraging machine learning and proprietary algorithms for automation, integration, and scalability through distributed cloud infrastructure, resulting in high-quality outcomes at a significantly higher ROI.

Collective Scientific enables pharmaceutical labs to discover novel drug candidates more quickly and effectively by transforming drug discovery into an engineering problem. Their software models de novo therapies, screening, refining, and optimizing in a single step, replacing traditional high-throughput screening. This process shortens the drug discovery timeline, allowing labs of all sizes to increase productivity and research a wider array of diseases. They provide a report with ranked, optimized compounds and their biosimilars ready for in vivo studies in under two weeks, leveraging machine learning and proprietary algorithms for automation, integration, and scalability through distributed cloud infrastructure, resulting in high-quality outcomes at a significantly higher ROI.